Evaluation of the Incidence of Gefitinib Induced Interstitial Lung Disease in Patients with Pulmonary Adenocarcinoma

Journal Title: Scholars Journal of Applied Medical Sciences - Year 2018, Vol 6, Issue 4

Abstract

Gefitinib induced interstitial lung disease (ILD) is a potentially serious adverse effect that should be considered in patients treated with gefitinib who present with unexpected dyspnea. This single-institution retrospective study aims to determine the incidence, clinical presentation, management, and clinical outcome in patients diagnosed with gefitinib induced ILD during the time frame of January 2013- December 2016. Out of 340 patients with EGFR-mutated pulmonary adenocarcinoma who received gefitinib as targeted therapy against EGFR exon 19 or exon 21 mutations, 36 patients developed features confirmatory of ILD. The median time of presentation of ILD was after the 3rd month of gefitinib use. Eighteen patients (50%) presented with acute onset dyspnea, and dry cough and further eighteen patients (50%) presented with insidious onset of dry cough and dyspnoea. Infectious pneumonitis was not considered as interstitial lung disease. Six of these patients had severe ILD. Four of these patients responded to corticosteroid treatment and supplemental oxygen. One patient recovered after intensive care and mechanical ventilation and one patient succumbed to ILD despite mechanical ventilation. Incidence of mild and serious ILD in this Indian patient population was 8.8% & 1.8%, respectively. Thus, gefitinib induced lung disease is not uncommon and thus requires a high index of suspicion for early diagnosis and drug discontinuation.

Authors and Affiliations

Kailash Chandra Pandey, Swaroop Revannasiddaiah, Nirdosh Kumar Pant, Lalit Mohan, Madhup Rastogi

Keywords

Related Articles

A Case of Tinea Capitis Favosa Due to Trichophyton schoenleinii in Morocco

Abstract: Tinea favosa is a chronic inflammatory dermatophytic infection of the scalp caused by T. schoenleinii. It is transmitted by contagion between individuals and is still endemic in Africa.We describe a singular...

Retrospective Analysis of Urinary Bladder Tumours- A Study from Central India

Abstract: Urinary bladder cancer accounts for approximately 7% cancers and 3% of cancer mortality in west, while in India it is the ninth most common cancer.Malignancy of the urinary bladder contributes significantly to...

Assessment of post-operative complications in emergency abdominal surgery in a tertiary care centre

Abstract: The aim is to assess the postoperative complications in emergency abdominal surgery at Bundelkhand Medical College, Sagar. The study was carried out in 350 patients who underwent emergency laparotomy in surgery...

Foreign Bodies in Aerodigestive Tract

Abstract: Foreign bodies in aero digestive tract are more common in children. The objective of our study is to know the nature of foreign bodies, age, sex distribution and site of lodgement. A prospective study was condu...

Occurrence of Metallo-Β-Lactmases Producing Pseudomonas aeruginosa among Clinical Isolates

Abstract: Pseudomonas aeruginosa is an increasingly prevalent opportunistic human pathogen and the most common gram negative bacterium found in nosocomial infection. Production of metallo-β- lactamase enzyme in Pseudomon...

Download PDF file
  • EP ID EP485328
  • DOI -
  • Views 103
  • Downloads 0

How To Cite

Kailash Chandra Pandey, Swaroop Revannasiddaiah, Nirdosh Kumar Pant, Lalit Mohan, Madhup Rastogi (2018). Evaluation of the Incidence of Gefitinib Induced Interstitial Lung Disease in Patients with Pulmonary Adenocarcinoma. Scholars Journal of Applied Medical Sciences, 6(4), 1575-1579. https://europub.co.uk/articles/-A-485328